Skip to content Skip to navigation

Can ‘Big Data’ Help Increase Drug Safety?

October 9, 2013
by John DeGaspari
| Reprints
Researchers use an EHR database to reduce adverse effects

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by adding a second drug to the diabetes drug rosiglitazone, adverse events dropped enormously. That suggests that drugs could be repurposed to improve drug safety, including lowering the risk of heart attacks. The research is published online Oct. 9 in the journal Science Translational Medicine.

 “Big data systems have a wealth of data, and when studied appropriately, can point to potentially safer combinations,” said Ravi Iyengar Ph.D., professor of pharmacology and director of the Systems Biology Center at the Icahn School of Medicine at Mount Sinai. He said that findings from big data analyses, although preliminary, can point to potentially safer combinations that can subsequently be tested in clinical trial. “We may be able to use FDA-approved drugs to prevent adverse events,” he said

In this study, investigators studied how drug combinations act through networks within cells, focusing on the diabetes drug rosiglitazone, an effective drug in controlling blood glucose. However, rosiglitazone has a serious side effect, increased heart attacks, which have restricted its use markedly. Investigators analyzed data from the FDAERS to see if second drugs could lower the rate heart attacks, and compared their results with Mount Sinai's electronic health records system. They found that the drug exanatide, often given along with rosiglitazone to get better control of blood glucose, also very substantially reduced the heart attack rate in rosiglitazone users. Iyengar’s team also found nearly 19,000 other drug combinations in the FDA database, where the second drug appears to reduce a wide range of side effects of the first drug.

The research team said that that the results are a valid starting point for developing clinical trials of safer drug combinations, and urged researchers and clinicians to contribute to big databases, such as the FDA’s Adverse Event Reporting System.

 

Topics

News

Report: Cyber Attackers Using Simple Tactics, Tools to Target Healthcare, Other Industries

The number of reported breach incidents in healthcare grew by 22 percent in 2016 from 269 breach incidents in 2015 to 328 last year, according to Symantec’s 2017 Internet Security Threat Report (ISTR).

The Sequoia Project Touts Interoperability Growth in Fifth Year

The Sequoia Project is celebrating its fifth anniversary this month by announcing that its various interoperability initiatives have grown by health organization participants, by geographic reach, and by the sheer number of health records exchanged electronically.

Report: HHS to Open Healthcare Cybersecurity Center

HHS will be opening a Cybersecurity and Communications Integration Center in which healthcare organizations and consumers can get educated about the risks of using mobile apps and data.

Survey: Two-Thirds of Healthcare Employees Share Confidential Data On Occasion

Seventy-two percent of employee say they would share sensitive, confidential or regulated company information under certain circumstances and 68 percent of healthcare employees report that they share confidential or regulated data on occasion, according to the Dell End-User Security Survey.

KLAS Report Examines Adoption of Sepsis Solutions and Impact on Outcomes

Sepsis detection and treatment is taking a big step forward as providers increasingly utilize surveillance and monitoring technology available through electronic medical records (EMR) vendors and third-party providers, according to a new report by KLAS Research.

Partners HealthCare, Persistent Systems Collaborate on Digital Platform for Clinical Care

Boston-based Partners HealthCare has announced a strategic collaboration with Persistent Systems to develop a new industry-wide open-source platform with the goal of bringing digital transformation to clinical care.